These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 25975847)

  • 21. Multinuclear MR characterization of a new hepatobiliary contrast agent. Preliminary results.
    Vander Elst L; Maton F; Laurent S; Seghi F; Muller RN
    Acta Radiol Suppl; 1997; 412():135-8. PubMed ID: 9240092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gadolinium meets medicinal chemistry: MRI contrast agent development.
    Zhang Z; Nair SA; McMurry TJ
    Curr Med Chem; 2005; 12(7):751-78. PubMed ID: 15853710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new class of Gd-based DO3A-ethylamine-derived targeted contrast agents for MR and optical imaging.
    Mishra A; Pfeuffer J; Mishra R; Engelmann J; Mishra AK; Ugurbil K; Logothetis NK
    Bioconjug Chem; 2006; 17(3):773-80. PubMed ID: 16704217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficiency, thermodynamic and kinetic stability of marketed gadolinium chelates and their possible clinical consequences: a critical review.
    Port M; Idée JM; Medina C; Robic C; Sabatou M; Corot C
    Biometals; 2008 Aug; 21(4):469-90. PubMed ID: 18344005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mesoporous silica nanospheres as highly efficient MRI contrast agents.
    Taylor KM; Kim JS; Rieter WJ; An H; Lin W; Lin W
    J Am Chem Soc; 2008 Feb; 130(7):2154-5. PubMed ID: 18217764
    [No Abstract]   [Full Text] [Related]  

  • 26. Design and characterization of a new irreversible responsive PARACEST MRI contrast agent that detects nitric oxide.
    Liu G; Li Y; Pagel MD
    Magn Reson Med; 2007 Dec; 58(6):1249-56. PubMed ID: 18046705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular magnetic resonance imaging with targeted contrast agents.
    Artemov D
    J Cell Biochem; 2003 Oct; 90(3):518-24. PubMed ID: 14523986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive evaluation of the physicochemical properties of Ln(III) complexes of aminoethyl-DO3A as pH-responsive T(1) -MRI contrast agents.
    Baranyai Z; Rolla GA; Negri R; Forgács A; Giovenzana GB; Tei L
    Chemistry; 2014 Mar; 20(10):2933-44. PubMed ID: 24590497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Magnetic resonance imaging using gadolinium-based contrast agents.
    Mitsumori LM; Bhargava P; Essig M; Maki JH
    Top Magn Reson Imaging; 2014 Feb; 23(1):51-69. PubMed ID: 24477166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of molecular descriptors in the design of gadolinium (III) chelates as MRI contrast agents.
    Maiocchi A
    Mini Rev Med Chem; 2003 Dec; 3(8):845-59. PubMed ID: 14529503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and evaluation of gadolinium complexes based on PAMAM as MRI contrast agents.
    Yan GP; Hu B; Liu ML; Li LY
    J Pharm Pharmacol; 2005 Mar; 57(3):351-7. PubMed ID: 15807991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemistry of paramagnetic and diamagnetic contrast agents for Magnetic Resonance Imaging and Spectroscopy pH responsive contrast agents.
    Pérez-Mayoral E; Negri V; Soler-Padrós J; Cerdán S; Ballesteros P
    Eur J Radiol; 2008 Sep; 67(3):453-8. PubMed ID: 18455343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MRI contrast agents: basic chemistry and safety.
    Hao D; Ai T; Goerner F; Hu X; Runge VM; Tweedle M
    J Magn Reson Imaging; 2012 Nov; 36(5):1060-71. PubMed ID: 23090917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A hexanuclear gadolinium-organic octahedron as a sensitive MRI contrast agent for selectively imaging glucosamine in aqueous media.
    He C; Wu X; Kong J; Liu T; Zhang X; Duan C
    Chem Commun (Camb); 2012 Sep; 48(74):9290-2. PubMed ID: 22875137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isoquinoline-based lanthanide complexes: bright NIR optical probes and efficient MRI agents.
    Caillé F; Bonnet CS; Buron F; Villette S; Helm L; Petoud S; Suzenet F; Tóth E
    Inorg Chem; 2012 Feb; 51(4):2522-32. PubMed ID: 22233349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PARACEST agents: modulating MRI contrast via water proton exchange.
    Zhang S; Merritt M; Woessner DE; Lenkinski RE; Sherry AD
    Acc Chem Res; 2003 Oct; 36(10):783-90. PubMed ID: 14567712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concepts of myocardial perfusion imaging in magnetic resonance imaging.
    Wilke N; Jerosch-Herold M; Stillman AE; Kroll K; Tsekos N; Merkle H; Parrish T; Hu X; Wang Y; Bassingthwaighte J
    Magn Reson Q; 1994 Dec; 10(4):249-86. PubMed ID: 7873354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and characterization of PEGylated Gd2O3 nanoparticles for MRI contrast enhancement.
    Ahrén M; Selegård L; Klasson A; Söderlind F; Abrikossova N; Skoglund C; Bengtsson T; Engström M; Käll PO; Uvdal K
    Langmuir; 2010 Apr; 26(8):5753-62. PubMed ID: 20334417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Promising strategies for Gd-based responsive magnetic resonance imaging contrast agents.
    Shen C; New EJ
    Curr Opin Chem Biol; 2013 Apr; 17(2):158-66. PubMed ID: 23141598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Robust texture features for response monitoring of glioblastoma multiforme on T1-weighted and T2-FLAIR MR images: a preliminary investigation in terms of identification and segmentation.
    Assefa D; Keller H; Ménard C; Laperriere N; Ferrari RJ; Yeung I
    Med Phys; 2010 Apr; 37(4):1722-36. PubMed ID: 20443493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.